Squeeze Report — August 11, 2026
Biotech dominates the high-conviction squeeze list, but the real story is the tension between extreme short positioning and aggressive dilution—NEO's convertible cap, NTLA's ATM overhang, and IBRX's going-concern warning all pit powder-keg technicals against heavy fundamental supply.
Today's top short-squeeze candidates
- #1TWSTTwist Bioscience Corporation C80
24% of float sold short · 9.7 days to cover · +38% over 20 days
SI 24%DTC 9.7$124.88+38% 20dHealthcare - #2ITGartner, Inc.80
18% of float sold short · 9.0 days to cover · +37% over 20 days
SI 18%DTC 9.0$193.17+37% 20dIndustrials - #3LQDALiquidia Corporation Common St79
20% of float sold short · 9.2 days to cover · +28% over 20 days
SI 20%DTC 9.2$91.03+28% 20dHealthcare - #4CHTRCharter Communications, Inc. C79
Aggressive buybacks have shrunk the float, but the pending Cox Transactions will issue ~33.6M new units, diluting any squeeze attempt.
SI 26%DTC 9.4$153.29+17% 20dCommunication Services - #5ASANAsana, Inc. Class A Common Sto76
39% of float sold short · 6.8 days to cover · +20% over 20 days
SI 39%DTC 6.8$9.23+20% 20dTechnology - #6AIC3.ai, Inc.76
32% of float sold short · 8.8 days to cover · +14% over 20 days
SI 32%DTC 8.8$10.40+14% 20dTechnology - #7CRSRCorsair Gaming, Inc. Common St76
A 45% post-earnings surge on a beat-and-raise is classic squeeze fuel, but a $300M shelf and 56M registered shares loom overhead.
SI 23%DTC 8.3$13.71+45% 20dTechnology - #8CERTCertara, Inc. Common Stock76
28% of float sold short · 7.8 days to cover · +19% over 20 days
SI 28%DTC 7.8$8.07+19% 20dHealthcare - #9UPWKUpwork Inc. Common Stock75
The August 15 convertible note maturity and $254M buyback are real catalysts, but a 20% post-earnings drop shows the fundamental tide is out.
SI 22%DTC 9.2$9.83+8% 20dIndustrials - #10GRPNGroupon, Inc. Common Stock75
67% of float sold short · 9.1 days to cover · -3% over 20 days
SI 67%DTC 9.1$22.95-3% 20dCommunication Services - #11SMMTSummit Therapeutics Inc. Commo75
34% of float sold short · 11.0 days to cover · -3% over 20 days
SI 34%DTC 11.0$14.87-3% 20dHealthcare - #12TSHATaysha Gene Therapies, Inc. Co74
Today's earnings update is a binary event for a 17% short interest name with a $212M active ATM and zero revenue.
SI 17%DTC 13.3$6.37+18% 20dHealthcare - #13SLDBSolid Biosciences Inc. Common74
23% of float sold short · 11.2 days to cover · -12% over 20 days
SI 23%DTC 11.2$8.56-12% 20dHealthcare - #14NRIXNurix Therapeutics, Inc. Commo74
18% of float sold short · 13.9 days to cover · +14% over 20 days
SI 18%DTC 13.9$25.88+14% 20dHealthcare - #15FAFirst Advantage Corporation Co73
Silver Lake's 12.5M-share secondary offering, announced yesterday, provides a perfect exit ramp for shorts to cover into strength.
SI 18%DTC 8.1$23.59+15% 20dIndustrials
See the full ranked board
This is the top sliver of 15 names we rank every day. The live board carries rank history, days-to-cover fuel gauges, AI research, and a backtested signal validator.
Open the live squeeze board →